Yolia Health

Yolia developed the Invisalign for the eyes. A contact lens and ophthalmic eye drop solution that fixes presbyopia with only 3 days of treatment.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location San Diego, CA, USA
  • Currency USD
  • Founded December 2004
  • Employees 6
  • Incorporation Type C-corp
  • Website yolia.com

Company Summary

Yolia is a bio-medical device company committed to helping eye care providers preserve, restore and enhance vision though cost-effective, non-invasive forms of treatment. We differentiate ourselves by delivering ophthalmic medical treatments though optometric sales channels. Yolia's technologies have been proven to correct vision without surgery.

Team

  • Alberto Osio
    CEO

    Alberto Osio first conceived of Yolia Health while earning an MBA at MIT's Sloan School of Management, where he was both an MIT Business Plan Competition semifinalist and a Harvard Biotech Business Plan Competition finalist. He has more than 10 years of international sales & marketing in China, US and Mexico. Alberto is also the Co-founder of Angel Ventures Mexico.

  • Eduardo Osio
    Operations

    Former Logistics Director for Herdez Corporation (MEX:HERDEZ), MBA from IPADE Business School.

  • Kenneth Kenyon
    Ophthalmology

    Adjunct Clinical Scientist at Schepens Eye Research Institute (Harvard) and Clinical Professor of Ophthalmology at Tufts University School of Medicine.

  • Dr. Jose Luis Monroy, OD
    Director of Sales and Marketing

    Former Country Manager for CooperVision and former Commercial Director for Bausch + Lomb and CibaVision.

  • Dr. Raul Suarez, MD
    Ophthalmology

    Former President of the Mexican Ophthalmology Association, Director of the Vision Institute in Mexico.

Advisors

  • Henry Weil
    Board of Directors & Prof at MIT
    Unconfirmed
    Praveen Tyle
    Former CSO for Bausch + Lomb
    Unconfirmed
    Tony Astorga
    Former SVP CFO at Blue Cross Blue Shield
    Unconfirmed
  • Alexander Klibanov, PhD
    Prof of Chemistry at MIT
    Unconfirmed
    David Castillerjos
    Director of Refractive Surgery at IDOC
    Rick Potvin
    Unconfirmed
  • Paul Karpecki
    Unconfirmed
    Stuart Grant
    Unconfirmed

Previous Investors

  • Jonathan Fleming
    Managing Director OxBio Partners
    Unconfirmed
    Charles Cooney
    Board Member Genzyme
    Unconfirmed
    Marc Moret
    Managing Director Lobnek
    Unconfirmed
  • Marcela Pons
    Family Office Amvita
    Unconfirmed
    fjpardo@nafin.gob.mx
    Investment Director Nafinsa Bank
    Unconfirmed
    MaryAnn Guerra
    Managing Director BioAccel
    Unconfirmed
  • Hernan Fernandez
    Managing Director for Angel Ventures Mexico
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free